158 related articles for article (PubMed ID: 28651487)
1. Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles.
Klahan S; Wong HS; Tu SH; Chou WH; Zhang YF; Ho TF; Liu CY; Yih SY; Lu HF; Chen SC; Huang CC; Chang WC
Tumour Biol; 2017 Jun; 39(6):1010428317705573. PubMed ID: 28651487
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.
Sonbul SN; Aleskandarany MA; Kurozumi S; Joseph C; Toss MS; Diez-Rodriguez M; Nolan CC; Mukherjee A; Martin S; Caldas C; Ellis IO; Green AR; Rakha EA
Mod Pathol; 2018 Nov; 31(11):1675-1682. PubMed ID: 29955149
[TBL] [Abstract][Full Text] [Related]
3. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.
Ejlertsen B; Jensen MB; Rank F; Rasmussen BB; Christiansen P; Kroman N; Kvistgaard ME; Overgaard M; Toftdahl DB; Mouridsen HT;
J Natl Cancer Inst; 2009 May; 101(10):729-35. PubMed ID: 19436035
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
Lee AH; Pinder SE; Macmillan RD; Mitchell M; Ellis IO; Elston CW; Blamey RW
Eur J Cancer; 2006 Feb; 42(3):357-62. PubMed ID: 16377180
[TBL] [Abstract][Full Text] [Related]
5. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.
Aleskandarany MA; Sonbul SN; Mukherjee A; Rakha EA
Pathobiology; 2015 Sep; 82(3-4):113-23. PubMed ID: 26330352
[TBL] [Abstract][Full Text] [Related]
6. An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients.
Cheng SH; Horng CF; Huang TT; Huang ES; Tsou MH; Shi LS; Yu BL; Chen CM; Huang AT
EBioMedicine; 2016 Mar; 5():74-81. PubMed ID: 27077114
[TBL] [Abstract][Full Text] [Related]
7. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H
Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016
[TBL] [Abstract][Full Text] [Related]
8. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
[TBL] [Abstract][Full Text] [Related]
9. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
[TBL] [Abstract][Full Text] [Related]
10. Global Transcriptional Changes Following Statin Treatment in Breast Cancer.
Bjarnadottir O; Kimbung S; Johansson I; Veerla S; Jönsson M; Bendahl PO; Grabau D; Hedenfalk I; Borgquist S
Clin Cancer Res; 2015 Aug; 21(15):3402-11. PubMed ID: 25840970
[TBL] [Abstract][Full Text] [Related]
11. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
[TBL] [Abstract][Full Text] [Related]
13. Is lymphovascular invasion degree one of the important factors to predict neoadjuvant chemotherapy efficacy in breast cancer?
Uematsu T; Kasami M; Watanabe J; Takahashi K; Yamasaki S; Tanaka K; Tadokoro Y; Ogiya A
Breast Cancer; 2011 Oct; 18(4):309-13. PubMed ID: 20574730
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
15. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
[TBL] [Abstract][Full Text] [Related]
18. Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer.
Fujii T; Yajima R; Hirakata T; Miyamoto T; Fujisawa T; Tsutsumi S; Ynagita Y; Iijima M; Kuwano H
Anticancer Res; 2014 Mar; 34(3):1255-9. PubMed ID: 24596369
[TBL] [Abstract][Full Text] [Related]
19. Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin.
Ishitobi M; Matsushita A; Nakayama T; Motomura K; Koyama H; Tamaki Y
J Surg Oncol; 2014 Sep; 110(3):265-9. PubMed ID: 24863697
[TBL] [Abstract][Full Text] [Related]
20. High lymphatic vessel density and presence of lymphovascular invasion both predict poor prognosis in breast cancer.
Zhang S; Zhang D; Gong M; Wen L; Liao C; Zou L
BMC Cancer; 2017 May; 17(1):335. PubMed ID: 28514957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
